|
WO2021075929A1
|
|
Composition, comprising an artemisia princeps leaf extract, for alleviation of skin damage
|
|
KR20200004277A
|
|
Pharmaceutical composition for forming film comprising NSAID
|
|
KR20200136721A
|
|
Composition for preventing or treating woman menopause symptoms comprising Cordyceps militaris Concentrate as an active ingredient
|
|
KR20200019476A
|
|
Suspension composition and dosage form of ibuprofen
|
|
KR20190125735A
|
|
Composition for hepatoprotective activity comprising Turmeric extract solution and Rice Soybean extract
|
|
KR20190101140A
|
|
Pharmaceutical composition for forming film comprising NSAID
|
|
KR20190028618A
|
|
Pharmarceutical composition for prevention and treatment of canities comprising extracts or fractions of Longanae Arillus as an active ingredient
|
|
KR20190012551A
|
|
Solid oral formulation for colon-targeted delivery of solubilized bisacodyl
|
|
KR101894521B1
|
|
Topical pharmaceutical composition for treating scar
|
|
KR20180072248A
|
|
Self-scanner, system and method for measuring fatigue using the self-scanner
|
|
EP3284484A1
|
|
Transdermal preparation containing antifungal active material
|
|
KR20160110209A
|
|
Pharmaceutical composition for treating fungal infections of keratinous tissue
|
|
KR20160028195A
|
|
Method for preparing solid probiotic coating composition with excellent acid-resistance and stability
|
|
KR20160014271A
|
|
Low irritating composition for skin whitening comprising hydroquinone
|
|
KR20160007049A
|
|
Improved anti-inflammatory and germicidal composition for preventing or alleviating periodontal disease
|
|
KR20140102026A
|
|
Film-forming pharmaceutical compositions for wound treatment and the production method thereof
|
|
WO2013022201A1
|
|
Process of preparing a stabilized and solubilized formulation of sirolimus derivatives
|
|
KR20130141100A
|
|
Novel composition for the treatment of gastroesophageal reflux disease
|
|
KR101151890B1
|
|
Method of preparing a stabilized and solubilized formulation of sirolimus derivatives
|
|
KR20130012044A
|
|
Bisphosphonate composition having enhanced oral bioavailability
|
